ANABAnaptysBio, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 11721
Ticker: ANAB
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2017-01-26
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: ANAB

Detail

Enriched 2026-08-14 20:47

Market cap: $1,687,091,247.38
Shares outstanding (class): 29,608,481
Shares outstanding (weighted): 29,608,481
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 104
Location: SAN DIEGO, CA
Homepage: https://www.anaptysbio.com
Description: AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Market cap and share counts drift.

Funds holding this security

103 funds · 103 positions · $166.40M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$34.08M	0.00%	614,546 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$28.41M	0.38%	512,175 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$24.79M	0.03%	446,925 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$12.13M	0.01%	218,706 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$10.66M	0.13%	192,136 NS	FIGI
VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS	—	$9.47M	0.09%	170,737 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$8.27M	0.07%	149,178 NS	FIGI
Nomura Healthcare Fund Delaware Group Equity Funds IV	—	$5.20M	0.78%	93,732 NS	FIGI
VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS	—	$2.67M	0.11%	48,190 NS	FIGI
Victory RS Science & Technology Fund Victory Portfolios	—	$2.67M	1.41%	48,060 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$2.55M	0.21%	45,994 NS	FIGI
Victory RS Small Cap Growth Fund Victory Portfolios	—	$1.72M	0.52%	30,930 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$1.63M	0.03%	29,321 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$1.34M	0.00%	24,126 NS	FIGI
HUSSMAN STRATEGIC MARKET CYCLE FUND Hussman Investment Trust	—	$1.11M	0.28%	20,000 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERANAB
FIGI_COMPOSITEBBG0026ZDHR0
FIGI_SHARE_CLASSBBG0026ZDHT8
CIK0001370053
ISINUS0327241065
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: AnaptysBio is a clinical-stage biopharmaceutical company developing antibody therapies, fitting the biotechnology industry within healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.